ロード中...

Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer

First-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), including gefitinib and erlotinib, have proven to be highly effective agents for advanced non-small cell lung cancer (NSCLC) in patients harboring an activating EGFR mutation such as the exon 19 deletion mutati...

詳細記述

保存先:
書誌詳細
主要な著者: Asami, Kazuhiro, Atagi, Shinji
フォーマット: Artigo
言語:Inglês
出版事項: Baishideng Publishing Group Inc 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4129529/
https://ncbi.nlm.nih.gov/pubmed/25302168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i4.646
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!